Determination of trans-resveratrol in human plasma by high-performance liquid chromatography. 1999

Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
Pharmascience, Montreal, Quebec, Canada. zzhu@pharmascience.com

The first method using high-performance liquid chromatography (HPLC) has been developed for the determination of trans-resveratrol in human plasma. The method involves a liquid--liquid extraction followed by reversed-phase HPLC with UV detection. The detection limit of trans-resveratrol in human plasma was 5.0 ng/ml. Standard curves are linear over the concentration range of 5.0-5000.0 ng/ml. Intra-assay variability ranged from 1.9 to 3.7% and inter-assay variability ranged from 2.5 to 4.0% at the concentration range of 15.0-4000.0 ng/ml.

UI MeSH Term Description Entries
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077185 Resveratrol A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro. 3,4',5-Stilbenetriol,3,4',5-Trihydroxystilbene,3,5,4'-Trihydroxystilbene,Resveratrol, (Z)-,Resveratrol-3-sulfate,SRT 501,SRT-501,SRT501,cis-Resveratrol,trans-Resveratrol,trans-Resveratrol-3-O-sulfate,Resveratrol 3 sulfate,cis Resveratrol,trans Resveratrol,trans Resveratrol 3 O sulfate
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013267 Stilbenes Organic compounds that contain 1,2-diphenylethylene as a functional group. Stilbene,Stilbene Derivative,Stilbene Derivatives,Stilbenoid,Stilbenoids,Derivative, Stilbene,Derivatives, Stilbene
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
March 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
March 2006, Journal of chromatography. A,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
June 1994, Journal of chromatography. B, Biomedical applications,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
August 2008, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
April 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
November 1997, Se pu = Chinese journal of chromatography,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
October 1982, Journal of chromatography,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
April 1999, Journal of chromatography. B, Biomedical sciences and applications,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
January 1986, Journal of chromatography,
Z Zhu, and G Klironomos, and A Vachereau, and L Neirinck, and D W Goodman
May 2004, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!